ATE360017T1 - L-ascorbinsäure-2-o-maleinsäure-a- tocopheroldiester-1-propanol addukt und verfahren zu dessen herstellung - Google Patents

L-ascorbinsäure-2-o-maleinsäure-a- tocopheroldiester-1-propanol addukt und verfahren zu dessen herstellung

Info

Publication number
ATE360017T1
ATE360017T1 AT02733329T AT02733329T ATE360017T1 AT E360017 T1 ATE360017 T1 AT E360017T1 AT 02733329 T AT02733329 T AT 02733329T AT 02733329 T AT02733329 T AT 02733329T AT E360017 T1 ATE360017 T1 AT E360017T1
Authority
AT
Austria
Prior art keywords
production
acid
maleic acid
ascorbic acid
propanol adduct
Prior art date
Application number
AT02733329T
Other languages
English (en)
Inventor
Kazumi Ogata
Noriko Saito
Kazuhiko Yamada
-Chome Tsurugaoka
Genta Maruyama
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE360017T1 publication Critical patent/ATE360017T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Otolaryngology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
AT02733329T 2001-06-06 2002-06-05 L-ascorbinsäure-2-o-maleinsäure-a- tocopheroldiester-1-propanol addukt und verfahren zu dessen herstellung ATE360017T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001171559 2001-06-06

Publications (1)

Publication Number Publication Date
ATE360017T1 true ATE360017T1 (de) 2007-05-15

Family

ID=19013310

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02733329T ATE360017T1 (de) 2001-06-06 2002-06-05 L-ascorbinsäure-2-o-maleinsäure-a- tocopheroldiester-1-propanol addukt und verfahren zu dessen herstellung

Country Status (8)

Country Link
US (1) US6828348B2 (de)
EP (1) EP1394161B1 (de)
JP (1) JP4179809B2 (de)
KR (1) KR100876371B1 (de)
AT (1) ATE360017T1 (de)
DE (1) DE60219620T2 (de)
ES (1) ES2281518T3 (de)
WO (1) WO2003006460A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007098467A2 (en) 2006-02-21 2007-08-30 Mary Kay, Inc. Stable vitamin c compositions
US10767259B2 (en) 2013-07-19 2020-09-08 Agilent Technologies, Inc. Components with an atomic layer deposition coating and methods of producing the same
US20150024152A1 (en) 2013-07-19 2015-01-22 Agilent Technologies, Inc. Metal components with inert vapor phase coating on internal surfaces
JP2019081726A (ja) * 2017-10-30 2019-05-30 日光ケミカルズ株式会社 エラスターゼ活性阻害剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4816901B1 (de) * 1969-05-21 1973-05-25
JPS59219295A (ja) * 1983-05-30 1984-12-10 Senjiyu Seiyaku Kk リン酸ジエステルまたはその塩およびそれらの製造法
JPS62205091A (ja) * 1986-03-04 1987-09-09 Senjiyu Seiyaku Kk 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤
JPH0499772A (ja) 1990-08-17 1992-03-31 Kanebo Ltd トコフェロール―５，６―０―イソプロピリデン―ｌ―アスコルビン酸―２―ジカルボン酸ジエステル，及びその製造方法，並びにそれより成るビタミンｃ・ビタミンｅ補給剤
JPH04149113A (ja) 1990-10-08 1992-05-22 Kanebo Ltd 美白化粧料
JP4346239B2 (ja) 1997-12-24 2009-10-21 千寿製薬株式会社 ビタミンｅ誘導体
KR20020025181A (ko) 1999-07-08 2002-04-03 요시다 쇼지 말레산(또는 푸마르산) 디에스테르 화합물

Also Published As

Publication number Publication date
WO2003006460A1 (fr) 2003-01-23
EP1394161A1 (de) 2004-03-03
KR100876371B1 (ko) 2008-12-29
EP1394161A9 (de) 2004-07-07
DE60219620D1 (de) 2007-05-31
ES2281518T3 (es) 2007-10-01
US6828348B2 (en) 2004-12-07
JP2003055374A (ja) 2003-02-26
US20040171676A1 (en) 2004-09-02
KR20040003046A (ko) 2004-01-07
EP1394161B1 (de) 2007-04-18
EP1394161A4 (de) 2004-06-30
JP4179809B2 (ja) 2008-11-12
DE60219620T2 (de) 2008-01-31

Similar Documents

Publication Publication Date Title
NL300933I2 (nl) Letermovir
PL1679386T3 (pl) Blacha cienka ze stali magnetycznej o dużej wytrzymałości oraz przetworzona część z niej i sposób ich wytwarzania
DE60026354D1 (de) Verfahren zur herstellung von methylcobalamin
ATE298322T1 (de) Ss'-bis-(alpha, alpha'-disubstituierte-alpha''- essigsäure)-trithio-carbonate und derivate davon als initiatoren, kettentransfer-verbindung, kettenabbruch-verbindung für kontrollierte radikalische polymerisationen sowie verfahren zu deren herstellung
WO2006028958A3 (en) Pyridyl inhibitors of hedgehog signalling
MX2007003031A (es) Compuestos heteroarilo para uso como betamimeticos en el tratamiento de enfermedades de vias respiratorias.
MXPA02011458A (es) Derivados de acilfenilurea, metodos para su produccion y uso de los mismos como farmacos.
HK1054967A1 (en) Method of amplifying nucleic acid by using double-stranded nucleic acid as template
BR0017043A (pt) Imidazo[1,3,5]triazinonas e sua aplicação
IL172015A (en) Phosphonate grouping shaft compounds, method of preparation and use thereof for the preparation of drugs for the treatment of viral infection
WO2007065684A3 (en) Bicyclic heteroyclic compounds as antiinflammatory or antiallergic agents
TW200509948A (en) Prevention of urogenital infections
DE60310759D1 (de) Pulver auf silber-basis, verfahren zu dessen herstellung, und härtbare siloxanzusammensetzung
CA2449480A1 (en) Process for producing methylcobalamin
ATE506346T1 (de) Verfahren zur herstellung von (z)-1-phenyl-1-(n,n-diethylaminocarbonyl)idomet ylcyclopropan
ATE360017T1 (de) L-ascorbinsäure-2-o-maleinsäure-a- tocopheroldiester-1-propanol addukt und verfahren zu dessen herstellung
WO2004033423A3 (en) Anticancer compounds
NL1027790A1 (nl) Werkwijze voor vervaardigen van een fosfaat van de lanthaniden en daaruit vervaardigd fosfaat.
ATE464382T1 (de) Mutageneseverfahren
DE60201984D1 (de) Werkzeugstahl von hoher zähigkeit, verfahren zum herstellen von teilen aus diesem stahl und so hergestellte teile
WO2005047278A3 (de) Substituierte dihydrochinazoline ii
BRPI0415529A (pt) derivados de bengamida, processos para produção dos mesmos e uso dos mesmos para tratamento de doenças cancerosas
ATE466847T1 (de) Verfahren zur herstellung von 14-beta- hydroxybaccatin-iii-1,14-carbonat
ATE537160T1 (de) Verfahren zur herstellung von 14beta- hydroxybaccatin-iii-1,14-carbonat
MXPA04000623A (es) Derivados de tetrahidropiridazina y su uso como pesticidas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties